About
Yasaman Kalantar-Motamedi is a computational biologist and biotech founder focused on AI-driven drug discovery, aging, and age-related disease. She is the CTO and co-founder of AGEMICA, a UK biotech developing vaccines and therapies for aging-related conditions. Public sources describe her as holding a Ph.D. from the University of Cambridge in AI for Drug Discovery, with earlier machine-learning training at University College London.
Areas of interest
longevityagingbiotechbioinformaticscomputational biologyAImachine learningdrug discoveryoncologycombination therapiesregenerative medicine